Zacks Investment Research upgraded shares of Revlon (NYSE:REV) from a sell rating to a hold rating in a research report sent to investors on Wednesday morning, Zacks.com reports.

According to Zacks, “Revlon, Inc. conducts its business exclusively through its subsidiary, Revlon Consumer Products Corp. and its subsidiaries. They manufacture, market and sell an extensive array of cosmetics and skin care, fragrances and personal care products. Their brand names are REVLON, COLORSTAY, REVLON AGE DEFYING, ALMAY and ULTIMA II in cosmetics; MOON DROPS, ETERNA 27, ULTIMA II and JEANNE GATINEAU in skin care; CHARLIE and FIRE & ICE in fragrances; and FLEX, OUTRAGEOUS, MITCHUM, COLORSTAY, COLORSILK, JEAN NATE, PLUSBELLE, BOZZANO and COLORAMA in personal care. “

Separately, ValuEngine lowered Zosano Pharma from a buy rating to a hold rating in a research report on Wednesday, May 1st.

Revlon stock opened at $20.30 on Wednesday. The firm’s 50 day simple moving average is $21.46. Revlon has a 52 week low of $14.00 and a 52 week high of $29.62.

Revlon (NYSE:REV) last issued its earnings results on Thursday, May 9th. The company reported ($1.20) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.73) by ($0.47). The business had revenue of $553.20 million during the quarter, compared to analysts’ expectations of $553.60 million. The business’s quarterly revenue was down 1.3% on a year-over-year basis. As a group, sell-side analysts anticipate that Revlon will post -2.76 earnings per share for the current year.

In other news, Director Ronald O. Perelman acquired 20,000 shares of the company’s stock in a transaction that occurred on Friday, June 7th. The shares were acquired at an average price of $23.51 per share, for a total transaction of $470,200.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Ronald O. Perelman acquired 30,000 shares of the company’s stock in a transaction that occurred on Wednesday, June 5th. The stock was purchased at an average price of $23.19 per share, for a total transaction of $695,700.00. The disclosure for this purchase can be found here. Insiders have acquired a total of 240,000 shares of company stock valued at $5,231,000 in the last quarter. Company insiders own 85.00% of the company’s stock.

A number of institutional investors have recently bought and sold shares of the stock. Rhumbline Advisers bought a new position in Revlon in the fourth quarter worth about $274,000. LPL Financial LLC bought a new position in Revlon in the fourth quarter worth about $294,000. BlackRock Inc. raised its stake in Revlon by 0.8% in the fourth quarter. BlackRock Inc. now owns 562,120 shares of the company’s stock worth $14,161,000 after buying an additional 4,248 shares in the last quarter. Raymond James & Associates bought a new position in Revlon in the fourth quarter worth about $1,488,000. Finally, Raymond James Financial Services Advisors Inc. bought a new position in Revlon in the fourth quarter worth about $399,000. Institutional investors and hedge funds own 13.48% of the company’s stock.

About Revlon

Revlon, Inc, through its subsidiaries, develops, manufactures, markets, distributes, and sells beauty and personal care products worldwide. The company's Relvon segment offers color cosmetics and beauty tools under the Revlon brand; and hair color under the Revlon ColorSilk and Revlon Professional brands.

Read More: What is the CBOE Russell 2000® Volatility Index?

Get a free copy of the Zacks research report on Revlon (REV)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Revlon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revlon and related companies with MarketBeat.com's FREE daily email newsletter.